ADELMAN DANIEL C MD 4
4 · Aimmune Therapeutics, Inc. · Filed May 12, 2020
Insider Transaction Report
Form 4
ADELMAN DANIEL C MD
Chief Medical Officer
Transactions
- Award
Common Stock, $0.0001 par value
2020-05-10+2,420→ 29,715 total
Footnotes (4)
- [F1]These shares represent restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest as to 100% of the underlying shares on September 11, 2020 (the "Vesting Date"), subject to the Reporting Person's continued service relationship with the Issuer on the Vesting Date.
- [F2]Includes 8,750 RSUs and will be settled in common stock upon vesting. The RSUs vest in three successive, equal, annual installments measured from March 1, 2020, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F3]Includes 8,906 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2019, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F4]Includes 7,031 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2018, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.